Life Science News

RSS

Applying a Proteomics-based Approach to the Clinic

Matthias Mann explains why applying proteomics-based technologies such as timsTOF could accelerate the diagnosis and prediction of human disease.

From Bruker Life Sciences Mass Spectrometry 20 Nov 2019

New database helps identify therapeutic targets to fight infectious diseases

Infectious diseases are caused by pathogenic microorganisms capable of entering, colonizing and growing within a host organism, thus producing an infection. Bacterial infections have been on the rise worldwide in recent years, but many mechanisms underlying bacterial pathogenesis are still poorly understood.

19 Nov 2019

Scientists grow complex organoids in the lab

Scientists at the University of Würzburg have successfully produced human tissues from stem cells. They have a complexity similar to that of normal tissue and are far superior to previous structures.

19 Nov 2019

Research findings can be used in antiviral development against enterovirus infections

Despite their prevalence, there are no antivirals on the market against enteroviruses, and vaccines have been developed only against couple of serotypes. The production of vaccines against all enterovirus serotypes is not feasible, and so antiviral drugs may be the solution for most of the enterovirus infections.

19 Nov 2019

Olympus X Line™ Series Objectives Honored with Innovation Award

Olympus’ X Line™ series objectives have been awarded a Laser Focus World Innovation Award, which celebrates the most innovative optics and photonics technologies, products, and systems.

From Evident Corporation - Life Sciences 19 Nov 2019

TARA's organ-on-a-chip technology can directly measure in vivo cardiac performance, study shows

TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA's human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance.

18 Nov 2019

U.S. Army project may lead to new class of self-healing materials and therapeutics for soldiers

Synthetic biologists working on a U.S. Army project have developed a process that could lead to a new class of synthetic polymers that may create new high-performance materials and therapeutics for Soldiers.

18 Nov 2019

Directional control of protocell's movement could lead to precision drug delivery

Synthetic protocells can be made to move toward and away from chemical signals, an important step for the development of new drug-delivery systems that could target specific locations in the body.

18 Nov 2019

Study uncovers how the molecule-sorting station in our cells is formed and maintained

The cells in our body are workshops that continuously operate to produce and process substances to keep us going. When a substance enters a cell for processing, it is surrounded by a portion of the cell's outer membrane to form a sac.

15 Nov 2019

Mining 'darkest' parts of the genome in cancer cells yields gold

Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate cancer.

15 Nov 2019

LUNAC announces spin out with £2.65 million funding to develop advanced anticoagulants

LUNAC Therapeutics today announced it has spun out of the University of Leeds with £2.65M funding in the first close of a Series A financing round.

15 Nov 2019

PhoreMost and Sentinel Oncology expand partnership to advance novel allosteric PLK1 inhibitor

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and Sentinel Oncology, today announce an expansion of their collaboration to accelerate the progression of SOL686, a novel allosteric Polo-like kinase 1 (PLK1) inhibitor through preclinical development and IND enabling studies for the treatment of Glioma.

From PhoreMost 15 Nov 2019

Lab Innovations 2019 achieves record breaking numbers

Lab Innovations celebrated its 8th edition on 30 & 31 October 2019, trumping all records for the event. Attracting 3,860 attendees - an impressive 24% increase on the previous year - this makes it the largest Lab Innovations to date.

From Lab Innovations 15 Nov 2019

Researchers decode molecular structure of cytochrome bd oxidase from E. coli

Both humans and many other creatures need oxygen for survival. In the conversion of nutrients into energy, the oxygen is converted to water, for which the enzyme oxidase is responsible. It represents the last step of the so-called respiratory chain.

14 Nov 2019

Study unravels how insulin interacts with its receptor

Since the discovery of insulin nearly 100 years ago, scientists have explored how it interacts with its receptor with the goal of improving the ability of therapeutic insulins to mimic the way insulin works in the body.

14 Nov 2019

New technique enables the study of transporter proteins at a single-molecule level

Like a boat helping passengers cross a river, transporters move substances across cell membranes. This process is fundamental to the healthy functioning of cells in life forms from bacteria to humans.

14 Nov 2019

Thermo Fisher Scientific becomes member of the Pistoia Alliance

Thermo Fisher Scientific, the world leader in serving science, has become a member of the Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers and academic groups working to lower barriers to innovation in life science and healthcare R&D through pre-competitive collaboration.

From Thermo Fisher Scientific Inc. 14 Nov 2019

Lonza launches new basal and feed medium to optimize protein production

Lonza has further expanded its cell culture media portfolio with the addition of the eCHO Basal Medium and Feed, which has been designed to optimize protein production by delivering a consistent yield and highly viable cells while keeping lactate levels to a minimum for optimal protein integrity.

From Lonza 14 Nov 2019

Turbine secures institutional financing of €3m to expand potential of simulation-first drug discovery

Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures.

From Turbine Simulated Cell Technologies Ltd. 14 Nov 2019

LG Chem Life Sciences expands collaboration with Avacta

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences, part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas.

From LG Chem Life Sciences Innovation Center, Inc. 14 Nov 2019

Life Science News

Applying a Proteomics-based Approach to the Clinic

New database helps identify therapeutic targets to fight infectious diseases

Scientists grow complex organoids in the lab

Research findings can be used in antiviral development against enterovirus infections

Olympus X Line™ Series Objectives Honored with Innovation Award

TARA's organ-on-a-chip technology can directly measure in vivo cardiac performance, study shows

U.S. Army project may lead to new class of self-healing materials and therapeutics for soldiers

Directional control of protocell's movement could lead to precision drug delivery

Study uncovers how the molecule-sorting station in our cells is formed and maintained

Mining 'darkest' parts of the genome in cancer cells yields gold

LUNAC announces spin out with £2.65 million funding to develop advanced anticoagulants

PhoreMost and Sentinel Oncology expand partnership to advance novel allosteric PLK1 inhibitor

Lab Innovations 2019 achieves record breaking numbers

Researchers decode molecular structure of cytochrome bd oxidase from E. coli

Study unravels how insulin interacts with its receptor

New technique enables the study of transporter proteins at a single-molecule level

Thermo Fisher Scientific becomes member of the Pistoia Alliance

Lonza launches new basal and feed medium to optimize protein production

Turbine secures institutional financing of €3m to expand potential of simulation-first drug discovery

LG Chem Life Sciences expands collaboration with Avacta

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest Life Science News